New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 20, 2013
10:48 EDTAMRNAmarin shares slightly lower after FDA updates Orange Book
Amarin shares are down 10c, or 1.15%, to $8.57 after an update in the FDA's Orange Book regarding the company's drug Vascepa said, "There is no unexpired exclusivity for this product." The FDA posting noted that the Orange Book Data was updated through January, 2013 and that patent and generic drug product data was last updated on February 19. Reference Link
News For AMRN From The Last 14 Days
Check below for free stories on AMRN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2014
11:20 EDTAMRNHigh option volume stocks:
High option volume stocks: AMRN EWT HIMX PTEN URBN MTW VPRT MTH OTEX ZLTQ
09:26 EDTAMRNOn The Fly: Pre-market Movers
Subscribe for More Information
09:11 EDTAMRNAmarin up 12% to $1.78 after positive mention by Adam Feuerstein
Subscribe for More Information
09:10 EDTAMRNAmarin mentioned positively by The Street's Adam Feuerstein
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use